Diagnostic Ansers

Founded: 2012 • Age: 14 yrs
SERS-active nanoparticles are developed for diagnostics and chemical detection.
Request Access

About Diagnostic Ansers

Diagnostic Ansers is a company founded in 2012.. Diagnostic Ansers operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Biological Dynamics, among others.

  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Quantum & Emerging Technologies
Technology → Quantum & Emerging Technologies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $5 K (USD), Grant

    Jun 01, 2016

  • Investors
    Jenoptik

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Diagnostic Ansers

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $5,000
  • First Round

    (01 Jul 2015)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2016 Amount Grant - Diagnostic Ansers Valuation

investors

Jul, 2015 Amount Grant - Diagnostic Ansers Valuation

investors

Jul, 2015 Amount Grant - Diagnostic Ansers Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Diagnostic Ansers

Diagnostic Ansers has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Jenoptik and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Provider of products and services for photonics market
Founded Year Domain Location
A government-backed foundation providing seed-stage investments to support small businesses.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Diagnostic Ansers

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Diagnostic Ansers

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Diagnostic Ansers Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Diagnostic Ansers

Diagnostic Ansers operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Biological Dynamics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Diagnostic Ansers

Frequently Asked Questions about Diagnostic Ansers

When was Diagnostic Ansers founded?

Diagnostic Ansers was founded in 2012 and raised its 1st funding round 3 years after it was founded.

What does Diagnostic Ansers do?

Diagnostic Ansers was founded in 2012 and focuses on the diagnostics and trace chemical detection sector. Ink-jet printed surface enhanced Raman spectroscopy (SERS)-active substrates are developed and marketed for these applications. Surface plasmon resonant spherical gold and silver nanoparticles are provided as bases for SERS measurements. Sensors are employed in swab and dipstick formats to identify traces of explosives, narcotics, and contaminants.

Who are the top competitors of Diagnostic Ansers?

Diagnostic Ansers's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Who are Diagnostic Ansers's investors?

Diagnostic Ansers has 2 investors. Key investors include Jenoptik, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available